ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/S-nitrosoglutathione
C10H16N4O7S
336.32 g/mol
Research ReagentWarning

Gsno

CAS57564-91-7EC637-341-5
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

S-Nitrosoglutathione (GSNO) is an endogenous S-nitrosothiol that serves as a critical carrier and donor of bioavailable nitric oxide (NO) in cellular signaling. It is widely used as a research reagent for studying NO release, free radical reactions, and related biochemical pathways.

Nitric oxide donor in biochemical researchTool for studying S-nitrosothiol-mediated signalingReagent for free radical chain propagation studies

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Gsno?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.77

Oxiglutatione

CAS27025-41-8

pharmaceutical raw material

ReferenceSame Category

Tris(dimethylamino)methane

CAS5762-56-1

research compound

ReferenceSame Category

Morpholin-4-ol

CAS5765-63-9

research compound

ReferenceSame Category

1,8-Diazabicyclo[5.4.0]undec-7-ene phenol salt

CAS57671-19-9

research compound

ReferenceSame Category

{3-[(3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]propyl}propanedioic acid

CAS57671-79-1

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Harmful
Harmful
Warning
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name

(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-nitrososulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

InChIKey

HYHSBSXUHZOYLX-WDSKDSINSA-N

SMILES

C(CC(=O)N[C@@H](CSN=O)C(=O)NCC(=O)O)[C@@H](C(=O)O)N

Synonyms (23)
  • SNOG
  • Glutathione thionitrite
  • Nitrosoglutathione
  • RVC 588 (PEPTIDE)
  • S-NITROSO-L-GLUTATHIONE
  • S-Nitroso-GSH
  • S-Nitrosoglutathione (GSNO)
  • S-Nitrosoglutatione
  • S-nitrosoglutathione
  • gsno
  • s-nitrosylglutathione

Sourcing Gsno?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→